Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z (Devin Coldewey/TechCrunch)

Devin Coldewey / TechCrunch: Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z  —  Putting AI to work in the healthcare industry is a tricky business; it's even more so in oncology, where the stakes are especially high.

May 31, 2024 - 01:00
182150
Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z (Devin Coldewey/TechCrunch)

Devin Coldewey / TechCrunch:
Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z  —  Putting AI to work in the healthcare industry is a tricky business; it's even more so in oncology, where the stakes are especially high.

This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.